| AMD1P2 |
|
adenosylmethionine decarboxylase 1 pseudogene 2
|
|
|
0.608 |
0.538 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| IDDM7 |
|
insulin dependent diabetes mellitus 7
|
|
|
0.861 |
0.192 |
| MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TRD |
|
T cell receptor delta locus
|
|
|
0.650 |
0.692 |
| XBP1P1 |
|
X-box binding protein 1 pseudogene 1
|
|
|
0.653 |
0.692 |
| NTT |
|
Noncoding transcript in T cells
|
|
|
0.743 |
0.462 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| CYCSP51 |
|
CYCS pseudogene 51
|
|
|
0.751 |
0.423 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |